Impact of gut microbiota on diabetes mellitus

Diabetes and Metabolism

Volumn 42, Issue 5, 2016, Pages 303-315

  Blandino, G ^a   Inturri, R ^a   Lazzara, F ^a   Di Rosa, M ^a   Malaguarnera, L ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Diabetes mellitus; Diabetic complications; Gut microbiota; Inflammation

Indexed keywords

ANIMAL; DIABETES MELLITUS; HUMAN; INFLAMMATION; INTESTINE FLORA; MOUSE; OBESITY;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; MICE; OBESITY;

EID: 84969940834     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2016.04.004     Document Type: Review

References (129)

1. [1] Turnbaugh, P.J., Ley, R.E., Hamady, M., Fraser-Liggett, C.M., Knight, R., Gordon, J.I., The human microbiome project. Nature 449 (2007), 804–810.
2. [2] Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
3. [3] Conlon, M.A., Bird, A.R., The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7 (2014), 17–44.
4. [4] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
5. [5] Wu, H., Tremaroli, V., Bäckhed, F., Linking microbiota to human diseases: a systems biology perspective. Trends Endocrinol Metab 26 (2015), 758–770.
6. [6] Haro, C., Montes-Borrego, M., Rangel-Zúñiga, O.A., Alcalá-Díaz, J.F., Gómez-Delgado, F., Pérez-Martínez, P., et al. Two healthy diets modulate gut microbial community improving insulin sensitivity in a human obese population. J Clin Endocrinol Metab, 27, 2015, jc20153351.
7. [7] Mejía-León, M.E., Barca, A.M., Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients 7 (2015), 9171–9184.
8. [8] Vasu, S., McClenaghan, N.H., McCluskey, J.T., Flatt, P.R., Mechanisms of toxicity by proinflammatory cytokines in a novel human pancreatic beta cell line, 1.1B4. Biochim Biophys Acta 1840 (2014), 136–145.
9. [9] Burokas, A., Moloney, R.D., Dinan, T.G., Cryan, J.F., Microbiota regulation of the mammalian gut-brain axis. Adv Appl Microbiol 91 (2015), 1–62.
10. [10] Chen, J., Li, Y., Tian, Y., Huang, C., Li, D., Zhong, Q., et al. Interaction between microbes and host intestinal health: modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr Protein Pept Sci 16 (2015), 592–603.
11. [11] Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
12. [12] Dominguez-Bello, M.G., Costello, E.K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107 (2010), 11971–11975, 10.1073/pnas.1002601107.
13. [13] Power, S.E., O'Toole, P.W., Stanton, C., Ross, R.P., Fitzgerald, G.F., Intestinal microbiota, diet and health. Br J Nutr 111 (2014), 387–402.
14. [14] Mika, A., Van Treuren, W., González, A., Herrera, J.J., Knight, R., Fleshner, M., Exercise is more effective at altering gut microbial composition and producing stable changes in lean mass in juvenile versus adult male F344 rats. PLoS One, 10, 2015, e0125889.
15. [15] Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 5 (2011), 71–86.
16. [16] Bäckhed F1, Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
17. [17] Rajilić-Stojanović M1, Smidt, H., de Vos, W.M., Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 9 (2007), 2125–2136.
18. [18] Kurakawa, T., Ogata, K., Matsuda, K., Tsuji, H., Kubota, H., Takada, T., et al. Diversity of intestinal clostridium coccoides group in the Japanese population, as demonstrated by reverse transcription-quantitative PCR. PLoS One, 10, 2015, e0126226.
19. [19] Li, T., Chiang, J.Y., Bile acids as metabolic regulators. Curr Opin Gastroenterol 31 (2015), 159–165.
20. [20] Fiorucci, S., Mencarelli, A., Palladino, G., Cipriani, S., Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 30 (2009), 570–580.
21. [21] Prawitt, J., Caron, S., Staels, B., Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep 11 (2011), 160–166.
22. [22] Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10 (2009), 167–177.
23. [23] Zhang, M., Chekan, J.R., Dodd, D., Hong, P.Y., Radlinski, L., Revindran, V., et al. Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. Proc Natl Acad Sci U S A 111 (2014), E3708–E3717.
24. [24] Kotzampassi, K., Giamarellos-Bourboulis, E.J., Stavrou, G., Obesity as a consequence of gut bacteria and diet interactions. ISRN Obes, 2014, 2014, 651895.
25. [25] Arumugam M1, Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
26. [26] Yuan, S.Y., Rigor, R.R., Regulation of endothelial barrier function. 2010, Morgan & Claypool Life Sciences, San Rafael (CA).
27. [27] Naydenov, N.G., Ivanov, A.I., Adducins regulate remodeling of apical junctions in human epithelial cells. Mol Biol Cell 21 (2010), 3506–3517.
28. [28] Gassler, N., Rohr, C., Schneider, A., Kartenbeck, J., Bach, A., Obermüller, N., et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 281 (2001), G216–G228.
29. [29] Guttman, J.A., Li, Y., Wickham, M.E., Deng, W., Vogl, A.W., Finlay, B.B., Attaching and effacing pathogen-induced tight junction disruption in vivo. Cell Microbiol 8 (2006), 634–645.
30. [30] Bruewer, M., Samarin, S., Nusrat, A., Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 1072 (2006), 242–252.
31. [31] Rosenstiel, P., Stories of love and hate: innate immunity and host-microbe crosstalk in the intestine. Curr Opin Gastroenterol 29 (2013), 125–132.
32. [32] Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun, 5, 2014, 5648.
33. [33] Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
34. [34] Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE, 7, 2012, e47713.
35. [35] Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K.S., McIntire, C.R., LeBlanc, P.M., et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32 (2010), 367–378.
36. [36] Zaki, M.H., Boyd, K.L., Vogel, P., Kastan, M.B., Lamkanfi, M., Kanneganti, T.D., The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32 (2010), 379–391.
37. [37] Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
38. [38] Larsen, N., Vogensen, F.K., van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085.
39. [39] Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18 (2010), 190–195.
40. [40] Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101 (2004), 15718–15723.
41. [41] Bäckhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104 (2007), 979–984.
42. [42] Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105 (2008), 16767–16772.
43. [43] Moya-Pérez, A., Neef, A., Sanz, Y., Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS One, 10, 2015, e0126976.
44. [44] Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 (2007), 2374–2383.
45. [45] Walsh, C.J., Guinane, C.M., Hill, C., Ross, R.P., O'Toole, P.W., Cotter, P.D., In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database. BMC Microbiol, 15, 2015, 183.
46. [46] Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
47. [47] Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106 (2009), 2365–2370.
48. [48] Kong, L.C., Wuillemin, P.H., Bastard, J.P., Sokolovska, N., Gougis, S., Fellahi, S., et al. Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach. Am J Clin Nutr 98 (2013), 1385–1394.
49. [49] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
50. [50] Chen, J., He, X., Huang, J., Diet effects in gut microbiome and obesity. J Food Sci 79 (2014), R442–R451.
51. [51] Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
52. [52] Goulet, O., Potential role of the intestinal microbiota in programming health and disease. Nutr Rev 73:Suppl 1 (2015), 32–40.
53. [53] Lê, K.A., Li, Y., Xu, X., Yang, W., Liu, T., Zhao, X., et al. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population. Front Physiol, 3, 2013, 496.
54. [54] Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54:Pt 5 (2004), 1469–1476.
55. [55] Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (2011), 2775–2786.
56. [56] Karlsson, C.L., Onnerfält, J., Xu, J., Molin, G., Ahrné, S., Thorngren-Jerneck, K., The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 20 (2012), 2257–2261.
57. [57] Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S., et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2014), 727–735.
58. [58] Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110 (2013), 9066–9071.
59. [59] Hansen, C.H., Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sørensen, S.J., et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55 (2012), 2285–2294.
60. [60] Lau, K., Benitez, P., Ardissone, A., Wilson, T.D., Collins, E.L., Lorca, G., et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 186 (2011), 3538–3546.
61. [61] Hänninen A1, Nurmela, R., Maksimow, M., Heino, J., Jalkanen, S., Kurts, C., Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol 170 (2007), 240–250.
62. [62] Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
63. [63] Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
64. [64] Cerf-Bensussan, N., Gaboriau-Routhiau, V., The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 10 (2010), 735–744.
65. [65] Longman, R.S., Yang, Y., Diehl, G.E., Kim, S.V., Littman, D.R., Microbiota: host interactions in mucosal homeostasis and systemic autoimmunity. Cold Spring Harb Symp Quant Biol 78 (2013), 193–201.
66. [66] Virtanen, S.M., Nevalainen, J., Kronberg-Kippilä, C., Ahonen, S., Tapanainen, H., Uusitalo, L., et al. Food consumption and advanced β cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr 95 (2012), 471–478.
67. [67] Lamb, M.M., Miller, M., Seifert, J.A., Frederiksen, B., Kroehl, M., Rewers, M., et al. The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes 16 (2015), 31–38.
68. [68] Birgisdottir, B.E., Hill, J.P., Thorsson, A.V., Thorsdottir, I., Lower consumption of cow milk protein A1 beta-casein at 2 years of age, rather than consumption among 11- to 14-year-old adolescents, may explain the lower incidence of type 1 diabetes in Iceland than in Scandinavia. Ann Nutr Metab 50 (2006), 177–183.
69. [69] Calderón de la Barca, A.M., Mejia-León, M.E., Are dietary caseins related to the onset and evolution of type 1 diabetes and celiac disease?., 1st ed. Ventimiglia, A.M., Birkenhäger, J.M., (eds.) Casein: Production, Uses and Health Effects, 1, 2012, Nova Science Publishers Inc, New York, NY, USA, 195–208.
70. [70] Monetini, L., Cavallo, M.G., Manfrini, S., Stefanini, L., Picarelli, A., Di Tola, M., et al. Antibodies to bovine beta-casein in diabetes and other autoimmune diseases. Horm Metab Res 34 (2002), 455–459.
71. + T-cell proliferation responses to wheat polypeptide stimulation in children at different stages of type 1 diabetes autoimmunity. Pediatr Diabetes 16 (2015), 177–188.
72. [72] Kahaly, G.J., Hansen, M.P., Type 1 diabetes associated autoimmunity. Autoimmun Rev, 2016 [pii: S1568-9972(16)30044-1].
73. [73] Everard, A., Geurts, L., Van Roye, M., Delzenne, N.M., Cani, P.D., Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One, 7, 2012, e33858.
74. [74] Wapenaar, M.C., Monsuur, A.J., van Bodegraven, A.A., Weersma, R.K., Bevova, M.R., Linskens, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 54 (2008), 463–467.
75. [75] Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Tripathi, A., Sapone, A., et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 41 (2006), 408–419.
76. [76] Neal, M.D., Leaphart, C., Levy, R., Prince, J., Billiar, T.R., Watkins, S., et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176 (2006), 3070–3079.
77. [77] Ryan, V.H., German, A.J., Wood, I.S., Hunter, L., Morris, P., Trayhurn, P., NGF gene expression and secretion by canine adipocytes in primary culture: upregulation by the inflammatory mediators LPS and TNFalpha. Horm Metab Res 40 (2008), 861–868.
78. [78] Malaguarnera, L., Imbesi, R., Di Rosa, M., Scuto, A., Castrogiovanni, P., Messina, A., et al. Action of prolactin, IFN-gamma, TNF-alpha and LPS on heme oxygenase-1 expression and VEGF release in human monocytes/macrophages. Int Immunopharmacol 5 (2005), 1458–1469.
79. [79] Poggi, M., Bastelica, D., Gual, P., Iglesias, M.A., Gremeaux, T., Knauf, C., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50 (2007), 1267–1276.
80. [80] Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 7, 2012, e47713.
81. [81] Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y., Weiser, J.N., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16 (2010), 228–231.
82. [82] Pekkala, S., Munukka, E., Kong, L., Pöllänen, E., Autio, R., Roos, C., et al. Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation. Obesity (Silver Spring) 23 (2015), 581–590.
83. [83] Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
84. [84] Mobegi, F.M., van Hijum, S.A., Burghout, P., Bootsma, H.J., de Vries, S.P., van der Gaast-de Jongh, C.E., et al. From microbial gene essentiality to novel antimicrobial drug targets. BMC Genomics, 15, 2014, 958.
85. [85] Telesford, K.M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M.A., et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 6 (2015), 234–242.
86. [86] Bereswill, S., Fischer, A., Plickert, R., Haag, L.M., Otto, B., Kühl, A.A., et al. Novel murine infection models provide deep insights into the “ménage à trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One, 6, 2011, e20953.
87. [87] Hall, J.A., Bouladoux, N., Sun, C.M., Wohlfert, E.A., Blank, R.B., Zhu, Q., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29 (2008), 637–649.
88. [88] Burrows, M.P., Volchkov, P., Kobayashi, K.S., Chervonsky, A.V., Microbiota regulates type 1 diabetes through Toll-like receptors. Proc Natl Acad Sci U S A 112 (2015), 9973–9977.
89. [89] Horváth, V.J., Putz, Z., Izbéki, F., Körei, A.E., Gerő, L., Lengyel, C., et al. Diabetes-related dysfunction of the small intestine and the colon: focus on motility. Curr Diab Rep, 15, 2015, 94.
90. [90] Hooper, L.V., Littman, D.R., Macpherson, A.J., Interactions between the microbiota and the immune system. Science 336 (2012), 1268–7310.
91. [91] Zandecki, M., Vanden Berghe, P., Depoortere, I., Geboes, K., Peeters, T., Janssens, J., et al. Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB-rats. Neurogastroenterol Motil 20 (2008), 818–828.
92. [92] Hardt, P.D., Hauenschild, A., Jaeger, C., Teichmann, J., Bretzel, R.G., Kloer, H.U., High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci 48 (2003), 1688–1692.
93. [93] Janatuinen, E., Pikkarainen, P., Laakso, M., Pyörälä, K., Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 28 (1993), 427–432.
94. [94] Brown, C.T., Davis-Richardson, A.G., Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One, 6, 2011, e25792.
95. [95] Bódi, N., Talapka, P., Poles, M.Z., Hermesz, E., Jancsó, Z., Katarova, Z., et al. Gut region-specific diabetic damage to the capillary endothelium adjacent to the myenteric plexus. Microcirculation 19 (2012), 316–326.
96. [96] Atkinson, M.A., Bluestone, J.A., Eisenbarth, G.S., Hebrok, M., Herold, K.C., Accili, D., et al. How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes 60 (2011), 1370–1379.
97. [97] Bytzer, P., Talley, N.J., Hammer, J., Young, L.J., Jones, M.P., Horowitz, M., GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 97 (2002), 604–611.
98. [98] Lelic, D., Brock, C., Simrén, M., Frøkjaer, J.B., Søfteland, E., Dimcevski, G., et al. The brain networks encoding visceral sensation in patients with gastrointestinal symptoms due to diabetic neuropathy. Neurogastroenterol Motil 26 (2014), 46–58.
99. [99] Brock, C., Søfteland, E., Gunterberg, V., Frøkjær, J.B., Lelic, D., Brock, B., et al. Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. Diabetes Care 36 (2013), 3698–3705.
100. [100] Iyer, L.M., Aravind, L., Coon, S.L., Klein, D.C., Koonin, E.V., Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?. Trends Genet 20 (2004), 292–299.
101. [101] Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303 (2012), G1288–G1295.
102. [102] Sobko, T., Huang, L., Midtvedt, T., Norin, E., Gustafsson, L.E., Norman, M., et al. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med 41 (2006), 985–991.
103. [103] Rhee, S.H., Pothoulakis, C., Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:5 (2009), 306–314, 10.1038/nrgastro.2009.35.
104. [104] Plamboeck, A., Veedfald, S., Deacon, C.F., Hartmann, B., Vilsbøll, T., Knop, F.K., et al. The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1. Am J Physiol Regul Integr Comp Physiol 309 (2015), R544–R551.
105. [105] Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (2014), 506–514.
106. [106] Thomas, L.V., Suzuki, K., Zhao, J., Probiotics: a proactive approach to health. A symposium report. Br J Nutr 114:Suppl 1 (2015), S1–S15.
107. [107] Turroni, F., Ventura, M., Buttó, L.F., Duranti, S., O'Toole, P.W., Motherway, M.O., et al. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 71 (2014), 183–203.
108. [108] Blandino, G., Fazio, D., Di Marco, R., Probiotics: overview of microbiological and immunological characteristics. Expert Rev Anti Infect Ther 6 (2008), 497–508.
109. [109] Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., et al. Probiotics, prebiotics, and the host microbiome: the science of translation. Ann N Y Acad Sci 1306 (2013), 1–17.
110. [110] Sanders, M.E., Lenoir-Wijnkoop, I., Salminen, S., Merenstein, D.J., Gibson, G.R., Petschow, B.W., et al. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 1309 (2014), 19–29.
111. [111] Simon, M.C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., et al. Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care 38 (2015), 1827–1834.
112. [112] Gomes, A.C., Bueno, A.A., de Souza, R.G., Mota, J.F., Gut microbiota, probiotics and diabetes. Nutr J, 13, 2014, 60.
113. [113] Razmpoosh, E., Javadi, M., Ejtahed, H.S., Mirmiran, P., Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review. Diabetes Metab Res Rev 32 (2016), 143–168.
114. [114] Laitinen, K., Poussa, T., Isolauri, E., Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101 (2009), 1679–1687.
115. [115] Luoto, R., Laitinen, K., Nermes, M., Isolauri, E., Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 103 (2010), 1792–1799.
116. [116] Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28 (2012), 539–543.
117. [117] Calcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 48 (2005), 1565–1575.
118. [118] Ma, X., Hua, J., Li, Z., Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49 (2008), 821–830.
119. [119] Andersson, U., Bränning, C., Ahrné, S., Molin, G., Alenfall, J., Onning, G., et al. Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Benef Microbes 1 (2010), 189–196.
120. [120] Lu, Y.C., Yin, L.T., Chang, W.T., Huang, J.S., Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. J Biosci Bioeng 110 (2010), 709–715.
121. [121] Kingma, S.D., Li, N., Sun, F., Valladares, R.B., Neu, J., Lorca, G.L., Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J Nutr 141 (2011), 1023–1028.
122. [122] Lee, S.K., Yang, K.M., Cheon, J.H., Kim, T.I., Kim, W.H., Anti-inflammatory mechanism of Lactobacillus rhamnosus GG in lipopolysaccharide- stimulated HT-29 cell. Korean J Gastroenterol 60 (2012), 86–93.
123. [123] Bejar, W., Hamden, K., Ben Salah, R., Chouayekh, H., Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe 24 (2013), 4–11.
124. [124] Okada, Y., Tsuzuki, Y., Narimatsu, K., Sato, H., Ueda, T., Hozumi, H., et al. 1,4-Dihydroxy-2-naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin-10-deficient mice with colitis by suppressing macrophage-derived proinflammatory cytokines. J Leukoc Biol 94 (2013), 473–480.
125. [125] Oksaharju, A., Kooistra, T., Kleemann, R., van Duyvenvoorde, W., Miettinen, M., Lappalainen, J., et al. Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet. Br J Nutr 110 (2013), 77–85.
126. [126] Roopchand, D.E., Carmody, R.N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P.J., et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes 64 (2015), 2847–2858.
127. [127] Guo, Z., Zhang, J., Wang, Z., Ang, K.Y., Huang, S., Hou, Q., et al. Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep, 6, 2016, 20602.
128. [128] Xu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 9 (2015), 552–562.
129. [129] Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., Haslberger, A.G., Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity. Benef Microbes 5 (2014), 33–43.